azacitidine has been researched along with bix 01294 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Agirre, X; de Miguel, I; Fernandez Perez, R; Fraga, M; Garate, L; García-Barchino, MJ; Liu, Y; Martínez-Climent, JA; Miranda, E; Ordoñez, R; Oyarzabal, J; Prosper, F; Rabal, O; Roa, S; Sáez, E; San José-Enériz, E; Sánchez-Arias, JA; Santamarina, P; Ugarte, A; Vilas-Zornoza, A; Wu, W; Xu, M | 1 |
| Chiba, DE; Dos Santos, JL; Lopes, JR | 1 |
| Berkova, Z; Koblas, T; Leontovyč, I; Pektorova, L; Saudek, F; Zacharovova, K | 1 |
| Fiszbein, A; Kornblihtt, AR; Petrillo, E; Schor, IE | 1 |
| Barat, C; Dental, C; Ouellet, M; Proust, A; Tremblay, MJ | 1 |
| Beizer, A; Belitsky, G; Bugaeva, P; Fedorov, D; Katz, R; Kirsanov, K; Lesovaya, E; Lizogub, O; Maksimova, V; Shalginskikh, N; Usalka, O; Vlasova, O; Yakubovskaya, M | 1 |
| Gu, X; Li, B; Li, H; Li, M; Sun, X; Xu, P; Zhu, Y; Zuo, Q | 1 |
1 review(s) available for azacitidine and bix 01294
| Article | Year |
|---|---|
HIV latency reversal agents: A potential path for functional cure?
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency | 2021 |
7 other study(ies) available for azacitidine and bix 01294
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Modification Methylases; Drug Design; Enzyme Inhibitors; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Mice; Molecular Docking Simulation; Protein Conformation; Xenograft Model Antitumor Assays | 2018 |
The effect of epigenetic factors on differentiation of pancreatic progenitor cells into insulin-producing cells.
Topics: Azacitidine; Azepines; C-Peptide; Cell Culture Techniques; Cell Differentiation; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Keratin-19; Models, Biological; Models, Genetic; Pancreas; Pyrroles; Quinazolines; Stem Cells; Transcription Factors | 2011 |
Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation.
Topics: Alternative Splicing; Animals; Azacitidine; Azepines; Cell Differentiation; Cell Line, Tumor; Chromatin; Chromatin Immunoprecipitation; DNA Methylation; DNA Primers; Epigenesis, Genetic; Exons; Mice; Neural Cell Adhesion Molecules; Neurons; Quinazolines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sequence Analysis, DNA | 2013 |
HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.
Topics: Acetamides; Azacitidine; Azepines; Blood-Brain Barrier; Bryostatins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CCL2; Cytokines; Decitabine; HIV-1; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Phorbol Esters; Quinazolines; Receptors, Cell Surface; Virus Latency | 2017 |
HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes.
Topics: Azacitidine; Azepines; DNA Methylation; Epigenesis, Genetic; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Phthalimides; Quinazolines; Tryptophan | 2021 |
H3K9me2 regulates early transcription factors to promote mesenchymal stem‑cell differentiation into cardiomyocytes.
Topics: Animals; Azacitidine; Azepines; Cell Differentiation; Female; GATA4 Transcription Factor; Gene Knockdown Techniques; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Homeobox Protein Nkx-2.5; Male; MEF2 Transcription Factors; Mesenchymal Stem Cells; Myocytes, Cardiac; Primary Cell Culture; Quinazolines; Rats, Wistar; Transcription Factors; Troponin T | 2021 |